NRNP 6675 FINAL EXAM 3 LATEST VERSIONS /NRNP 6675 WEEK 11 FINAL REAL EXAM 300 QUESTIONS AND CORRECT ANSWERS | ALREADY GRADED A+ WALDEN
NRNP 6675 FINAL EXAM 3 LATEST VERSIONS /NRNP 6675 WEEK 11 FINAL REAL EXAM 300 QUESTIONS AND CORRECT ANSWERS | ALREADY GRADED A+ WALDEN 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Rapid dose escalation; parental route of administration; higher potency typical antipsychotics 2. Discrepancy between anatomical sex and gender is known as? B) Gender Discordance 3. Antipsychotic medication provides D2 blockage in the meso-coritcal pathway causing which of the following effects? B) Increases EPS Incorrect: reduces negative s/s, causes prolactinemia, reduces positive symptoms 4. Phencyclidine (PCP) and ketamine exert their unique behavioral effects by blocking which of the following receptors? D) NMDA type receptors Incorrect: GABA, serotonin, dopamine "receptors"
Geschreven voor
- Instelling
- NRNP 6675
- Vak
- NRNP 6675
Documentinformatie
- Geüpload op
- 8 november 2024
- Aantal pagina's
- 94
- Geschreven in
- 2024/2025
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
nrnp 6675
-
nrnp 6675 final exam 3 latest versions nrnp 6675
-
which of the following are risk factors for neurol
-
discrepancy between anatomical sex and gender is k
-
antipsychotic medication provides d2 bl
Ook beschikbaar in voordeelbundel